STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G

CRBP Schedule 13G filing by Citadel Advisors

Citadel Advisors reported beneficial ownership of 980.6K shares, representing 5.3% of CORBUS PHARMACEUTICALS HOLDI in this filing.

FiledNov 12, 2025
Ownership dateNov 4, 2025
Reported shares980.6K
Reported ownership5.3%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 0
Shared voting power 980.6K
Sole dispositive power 0
Shared dispositive power 980.6K
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$11.19as of Nov 12, 2025
Latest tracked price$9.62as of Aug 5, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
Citadel Advisors
CIK
CIK0001423053
Accession
0001104659-25-110417
Form
Schedule 13G
Open SEC filing View CRBP ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →